Improvement of peripheral nervous system manifestations of B-cell non-Hodgkin's lymphoma after rituximab therapy

J Peripher Nerv Syst. 2009 Jun;14(2):146-8. doi: 10.1111/j.1529-8027.2009.00224.x.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Demyelinating Diseases / drug therapy
  • Demyelinating Diseases / etiology
  • Demyelinating Diseases / pathology
  • Female
  • Humans
  • Lymphoma, B-Cell / complications*
  • Lymphoma, B-Cell / drug therapy*
  • Lymphoma, B-Cell / pathology
  • Male
  • Middle Aged
  • Peripheral Nervous System Diseases / drug therapy*
  • Peripheral Nervous System Diseases / etiology*
  • Peripheral Nervous System Diseases / pathology
  • Rituximab
  • Sural Nerve / pathology
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab